Investor Relations

2017 Press Releases

RSS RSS Feeds | E-mail Alerts Receive E-mail Alerts
Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
08/08/17Foamix Reports Second Quarter 2017 Financial Results and Provides Business UpdatePrinter Friendly Version
08/03/17Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101Printer Friendly Version
07/26/17Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for August 9Printer Friendly Version
06/29/17Foamix Pharmaceuticals Appoints David Domzalski as Chief Executive OfficerPrinter Friendly Version
06/15/17Foamix Pharmaceuticals to Present at the 2017 BIO International ConventionPrinter Friendly Version
06/12/17Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%Printer Friendly Version
06/01/17Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare ConferencePrinter Friendly Version
05/09/17Foamix Reports First Quarter 2017 Financial Results and Provides Business UpdatePrinter Friendly Version
05/01/17Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe AcnePrinter Friendly Version
04/27/17Foamix Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Health Care ConferencePrinter Friendly Version
04/26/17Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, May 10Printer Friendly Version
03/27/17Foamix Reports Topline Results from Phase 3 Trials for FMX101 in Patients with AcnePrinter Friendly Version
03/08/17Foamix Pharmaceuticals to Present at the Barclays Capital Global Healthcare ConferencePrinter Friendly Version
03/07/17Foamix Pharmaceuticals to Present at the ROTH Capital Partners 29th Annual Growth ConferencePrinter Friendly Version
02/27/17Foamix Pharmaceuticals to Present at the Cowen & Company 37th Annual Healthcare ConferencePrinter Friendly Version
02/23/17Foamix Pharmaceuticals to Participate in a Panel Discussion at the Dermatology Innovation ForumPrinter Friendly Version
02/22/17Foamix Reports Year End 2016 Financial Results and Provides Business UpdatePrinter Friendly Version
02/07/17Foamix Pharmaceuticals to Release Fiscal Year 2016 Financial Results and Host Conference Call & Webcast on Wednesday, February 22Printer Friendly Version
02/06/17Foamix Pharmaceuticals to Present at the 2017 BIO CEO & Investor ConferencePrinter Friendly Version